Sumitomo Pharma
4506.T
$3.60
Share price
-0.91%
Change (1 day)
-55.22%
Change (1 year)
Categories
Revenue for Sumitomo Pharma (4506.T)
Revenue in 2023 (TTM): $3.41 B
According to Sumitomo Pharma 's latest financial reports the company's current revenue (TTM) is $3.41 B. In 2022 the company made a revenue of $4.40 B a decrease over the years 2021 revenue that were of $4.93 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sumitomo Pharma from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $3.41 B | -22.3% |
| 2022 | $4.40 B | -10.92% |
| 2021 | $4.93 B | 0.65% |
| 2020 | $4.90 B | 13.99% |
| 2019 | $4.30 B | 5.63% |
| 2018 | $4.07 B | -0.81% |
| 2017 | $4.10 B | 9.88% |
| 2016 | $3.73 B | 13.8% |
| 2015 | $3.28 B | -7.2% |
| 2014 | $3.54 B | -3.12% |
| 2013 | $3.65 B | -15.91% |
| 2012 | $4.34 B | -5.04% |
| 2011 | $4.57 B | 6.24% |
| 2010 | $4.30 B | 52.8% |
| 2009 | $2.81 B |